Articles from Portal Innovations

Portal Innovations, a leading life science venture development engine, today announced its international expansion through a strategic partnership with Dublin City University (DCU). This collaboration was established under a Memorandum of Understanding which expands Portal’s footprint at DCU Alpha – Dublin City University’s Innovation Campus – where Portal opened space earlier this year. Portal’s expansion at DCU Alpha will help create new opportunities for biotech, medtech, quantum, and AI startups across Ireland, the UK, and Europe. Portal plans to introduce additional lab space to help address the region’s growing demand for physical infrastructure and specialized wet lab facilities to support emerging founders and early-stage companies.

Portal Innovations, a national venture creation and development platform, is partnering with the University of Chicago’s Polsky Center for Entrepreneurship and Innovation to design and manage a science startup incubator at Hyde Park Labs.

Portal Innovations, a life sciences venture capital firm, today announced its expansion into Houston, Texas, partnering with the Texas Medical Center (TMC) to drive early-stage biotech and medtech startups. The company will operate 30,000 square feet of world-class lab and office space in the TMC3 Collaborative Building within TMC’s new Helix Park complex, a 37-acre mixed-use campus with a focus on therapeutic and diagnostic research.

Portal Innovations, a leading life sciences venture development engine, announced today that it will be expanding its operations to South Boston in April, 2023. The Company, which specializes in early-stage life sciences venture creation and investments, will be launching its initial lab and office space in the Southline Boston building.

Portal Innovations today announced that it is partnering with Life Technologies Corporation, part of Thermo Fisher Scientific Inc. (NYSE: TMO) the world leader in serving science and a leading life sciences research provider of innovative technologies. This partnership will further Portal Innovations’ mission to provide premier scientific equipment and resources to its portfolio companies that work out of Portal’s 50,000 sq ft of life science laboratories in Fulton Labs in Chicago.

Portal Innovations today announced the expansion of its premier life sciences-focused venture development engine to Atlanta, Georgia, where it will invest in and provide the critical resources that early-stage companies need to grow and scale.

Portal Innovations continues its momentum in Chicago by launching the second phase of its operations with the opening of 35,000 square feet of premier wet and dry lab and office space at 400 North Aberdeen in Fulton Labs. The new facility will allow Portal, a life sciences venture development engine, to grow and scale its investment in early-stage biotech companies in Chicago.